icon-folder.gif   Conference Reports for NATAP  
 
  Infectious Disease Societyof America (IDSA)
IDSA 49th Annual Meeting
October 20-23, 2011
Boston, MA
Back grey_arrow_rt.gif
 
 
 
Analysis of lipid levels and neuropsychiatric events in treatment-naïve HIV-1-infected adults treated with rilpivirine or efavirenz over 96 weeks in ECHO and THRIVE
 
 
  Reported by Jules Levin IDSA Oct 20-23 2011 Boston, MA
 
Michael Sension,1 Mariette Botes,2 Dan Duiculescu,3 Gerd Fätkenheuer,4 Eric Florence,5 Claudio Gonsalez,6 Chien-Ching Hung,7 François Raffi,8 Timothy Wilkin,9 Robin Wood,10 Henri Deckx,11 Marita Stevens,11 Simon Vanveggel,11 Katia Boven12
 
1Comprehensive Care Center, Fort Lauderdale, FL, USA; 2MuelMed Hospital, Pretoria, South Africa; 3'Titu Maiorescu' University of Medicine and 'Dr Victor Babes' Hospital for Infectious and Tropical Diseases, Bucharest, Romania; 4University Hospital of Cologne, Germany;5Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium; 6Hospital Das Clinicas Da Faculdade De Medicina Da Universidade De Sao Paulo, São Paulo, Brazil; 7National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan;8University Hospital Hotel Dieu, Nantes, France; 9Weill Medical College of Cornell University, New York, NY, USA; 10Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; 11Tibotec BVBA, Beerse, Belgium; 12Tibotec, Inc., Titusville, NJ, USA

EACS1.gif

EACS2.gif

EACS3.gif

EACS4.gif

EACS5.gif

EACS6.gif

EACS7.gif

EACS8.gif

EACS9.gif

EACS10.gif